About MGC Pharmaceuticals Limited (MGCLF) — Dividend Analysis 2026
MGC Pharmaceuticals Limited, a bio-pharma company, develops and supplies phytomedicines in worldwide. The company produces and supplies medicinal cannabis products; and non-cannabis phytomedicines. Its principal product candidates include CimetrA, which is in phase III clinical trial for the symptomatic treatment of early COVID-19; CannEpil, a phase IIb cannabis-based therapy for drug-resistant Epilepsy; and CogniCann that is in phase II clinical trial for the symptomatic relief of Dementia. The company also provides ArtemiC range of products and cannabinoid products, as well as non-pharma products. In addition, it offers consulting services, including clinical research services. The company was formerly known as Erin Resources Limited and changed its name to MGC Pharmaceuticals Limited in December 2015. MGC Pharmaceuticals Limited was founded in 2014 and is based in West Perth, Australia.
Is MGCLF a good dividend investment in 2026?
MGCLF offers a 747.66% forward yield with a 50% payout ratio. Strand Safety Score: 0/100 (Critical Risk). The 5-year dividend CAGR of 0% is modest — investors should weigh current income against growth alternatives.
MGCLF DRIP calculator — what's the difference?
With DRIP on a $10,000 investment over 10 years, your MGCLF portfolio grows to $606.13M vs $10.99M without reinvestment. This is the compound interest effect in action.
MGCLF dividend growth history & forecast
MGCLF has grown its dividend by 0% over the last year and 0% annually over 5 years. At this pace, an investor who holds for 10+ years will see their yield on cost grow substantially above the current 747.66%.
Company generates negative FCF ($-12M) — borrowing to pay dividends
Debt Leverage0.0× Debt/EBITDA
0 / 30 pts
0/30
Company not generating EBITDA — debt servicing risk is elevated
Earnings Momentum-0.0B → -0.0B → -0.0B
0 / 30 pts
0/30
Company is reporting net losses — dividend sustainability is in question
OVERALL ASSESSMENT
High risk of dividend cut — weak fundamentals across multiple factors.
STRAND SCORE
0
/100
Strand Safety Score™ is proprietary to DividendFlow. Inputs: FCF, Debt/EBITDA, Net Income from SEC filings via FMP. Not financial advice. N/A for ETFs, pre-revenue companies, and tickers without income statements.
🌍 MGCLF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold MGCLF.
Gross yield
747.66%
Tax rate
15.00%
After-tax yield
635.51%
Real yield (−CPI)
632.71%
Account/Country
Tax Rate
After-tax Yield
Real Yield
$10K Annual Income
🇺🇸 Roth IRA / 401k
0%
747.66%
744.86%
$74,766 / yr
🇺🇸 US Taxable (15%) ✓
15%
635.51%
632.71%
$63,551 / yr
🇺🇸 US Taxable (20%)
20%
598.13%
595.33%
$59,813 / yr
🇬🇧 UK ISA
0%
747.66%
744.86%
$74,766 / yr
🇬🇧 UK Taxable
8.75%
682.24%
679.44%
$68,224 / yr
🇨🇦 TFSA
0%
747.66%
744.86%
$74,766 / yr
🇨🇦 CA Taxable
25%
560.75%
557.95%
$56,075 / yr
🇦🇺 Super (pension)
15%
635.51%
632.71%
$63,551 / yr
🇦🇺 AU Taxable
30%
523.36%
520.56%
$52,336 / yr
🇩🇪 DE Taxable
26.375%
550.46%
547.66%
$55,046 / yr
🇫🇷 FR Taxable
30%
523.36%
520.56%
$52,336 / yr
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 MGCLF Income Goal & Break-Even
Dividend Break-Even
1yr
Years for dividends to fully repay your MGCLF investment of $0.27/share (🇺🇸 US Taxable (15%) · 15.00% tax)
$10K invested · 10 Years
Dividends earned (DRIP)
$15.61M
Lost to inflation (2.8% CPI)
−$2.5K
Real purchasing power gain
$15.60M
12-month CPI (US BLS via FMP economic-indicators).
How much do I need to invest in MGCLF for:
Shares needed
14,118
Capital required
$3,777
Monthly income
$2,000
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 MGCLF Dividend Payment Schedule
MGCLF pays quarterly — 4 times per year. Next ex-div: TBD.
Jan
Feb
Mar
💰
Apr
May
Jun
💰
Jul
Aug
Sep
💰
Oct
Nov
Dec
💰
10 shares
$4.25 / payment
$17.00 / year after tax
100 shares
$42.50 / payment
$170.00 / year after tax
1,000 shares
$425.00 / payment
$1700.00 / year after tax
📊 MGCLF vs Healthcare Benchmarks
How MGCLF compares to typical Healthcare averages.
Benchmark: Healthcare
Dividend Yield▲+744.86% vs sectorBetter
MGCLF
747.66%
avg
2.80%
5Y Dividend CAGR▼-6.80% vs sectorBelow avg
MGCLF
0.00%
avg
6.80%
Payout Ratio▲-5.00% vs sectorBetter
MGCLF
50.00%
avg
55.00%
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for MGCLF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ MGCLF Insider Activity
No recent SEC filings reported in the last 90 days.
🔬
Financial Health Scores
Altman Z-Score
-16.13
🔴 Distress Zone — elevated dividend cut risk
Safe: >3.0 · Grey: 1.81–3.0 · Distress: <1.81
Piotroski F-Score
2/9
🔴 Weak fundamentals — dividend safety concern
Strong: 7–9 · Moderate: 4–6 · Weak: 0–3
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
📊 About This Data
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the MGCLF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →